Business
WBD studio lot gate 2
(Robyn Beck/Getty Images)
amassed media

Netflix reportedly made a mostly cash offer for Warner Bros. Discovery over the weekend

The WBD bidding war is heating up — what will the winner get?

Tom Jones

To the victor belong the spoils… and, possibly, the world of film and TV as we know it. 

While we enjoyed the long holiday weekend, a host of huge names like Paramount Skydance, Comcast, and Netflix had their bankers and lawyers working on a new round of bids for Warner Bros. Discovery, according to new reports. 

Whichever way you slice it

The latter of those companies, Netflix, already long the biggest streaming service in the world, is reportedly interested in just the studio business and HBO Max streaming platform from WBD, offering a bid consisting mostly of cash for those assets, Bloomberg reported at the start of the week.

Comcast has a similar idea. The telecoms and media giant wants to merge the same two segments with its NBCUniversal division, meaning that a successful bid from either would mean that Warner Bros. Discovery — the home of mega media brands like HBO and CNN as well as huge chunks of IP like the “Harry Potter” franchise and DC Comics characters via its studio business — could still go ahead with plans to spin off its major networks, per the reporting.

But what of the companies that want the entire WBD pie? What would they get in a deal that could nudge toward the $75 billion mark, if suitors stump up the $30-per-share price that Warner execs want?

WBD sankey
Sherwood News

In a particularly dramatic-sounding Bank of America note on Monday, a group of analysts wrote: “The global media industry stands at the precipice of historic transformation.” Still, when you look at the brands under the Warner Bros. Discovery umbrella (assembled after a merger between the companies that make up each half of its name) and consider the behemoths that could one day possess some of them, the BofA writers might have a point.

More Business

See all Business
business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.